Encompass Health reports Q2 2024 results; specifics unavailable in filing text

Encompass Health Corp

2024-Q2 EPS reported $2.22 revenue$2,617,200,000

Encompass Health issued press release on Aug 5, 2024 covering Q2 2024 financial results.
Supplemental information for Aug 6 earnings call also furnished (Exhibit 99.2).
Filing notes use of non-GAAP measures: adjusted EPS, Adjusted EBITDA, adjusted free cash flow.
No specific revenue, EPS, or guidance figures present in the provided filing excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.